FEATURED COMPANIES
- Amgen Inc.
- ATS Automation
- Becton
- CeQur S.A.
- Dickinson and Company
- Enable Injections
According to the report, the global wearable injectors market was valued at approximately USD 6.9 Billion in 2020 and is expected to reach a value of around USD 11.5 Billion by 2026, at a CAGR of around 8.9% between 2021 and 2026.
Wearable injectors are devices that can be worn on the body in the form of a patch or complete equipment for timely medicine inoculation. There are various kinds of medical condition in which timely injection of drugs are necessary for the normal functioning of the body when the person is affected from diabetes, Parkinson's disease, heart disorders, and cancer. These products help the patient suffering from chronic diseases live a normal life. These devices can also be connected to the body in the form of a tube via a tiny discreet instrument. Moreover, wearable injectors also have wireless connectivity and their operations or functionalities can be regulated through software.
The tremendous rise in the occurrence of chronic ailments like heart diseases, diabetes, and cancer will offer lucrative growth avenues for the market over the forecast timeline. According to the report of International Diabetes Federation, about 425 million persons were found be have been suffering from diabetes in 2017 and the figures are slated to hit nearly 629 million by 2045. Moreover, diabetic conditions need drug inoculation on time for maintaining normal body functioning. This will elevate the growth of the wearable injectors industry over the forecast timeline.
Furthermore, the launching of new technologies for maintaining the balance between disease management and lifestyles will further elevate the business growth during the forecast timeline. Moreover, technology has minimized the device size and made it user-friendly, thereby further accelerating the growth rate of the market over the forecast timeline. Nonetheless, growing acceptance of alternate modes of drug delivery will inhibit the scope of the market during the forecast timeframe.
The users easily wear these devices and are handled by wireless connection & software. Moreover, technological breakthroughs have reduced the equipment size, thereby further steering the segmental growth over the forecast timeline.
The growth of the segment during the forecast period is due to the high occurrence of cancer across the globe.
The growth of the market in North America is due to the presence of strong healthcare infrastructure along with growing incidences of chronic ailments. In addition to this, an increase in the research activities for biologics and the development of new injector design are a few of the major factors that are likely to steer the growth of the industry during the period from 2019 to 2027.
Furthermore, a rise in the acceptance of wearable injectors, favorable compensation policies, and bulge in healthcare spending are some of the aspects that will steer the regional market surge over the forecast timeline.
The key market players for the global wearable injectors market are Becton, Dickinson and Company, Johnson & Johnson Services, Inc., F. Hoffman-La Roche Ltd., Unilife Corporation, SteadyMed Therapeutics, Inc., Amgen, Inc., Insulet Corporation, Enable Injections, West Pharmaceuticals Services, Inc., CeQur S.A., ATS Automation, Tandem Diabetes Care, and Noble, among others.
Wearable injectors are devices that can be worn on the body in the form of a patch or complete equipment for timely medicine inoculation. There are various kinds of medical condition in which timely injection of drugs are necessary for the normal functioning of the body when the person is affected from diabetes, Parkinson's disease, heart disorders, and cancer. These products help the patient suffering from chronic diseases live a normal life. These devices can also be connected to the body in the form of a tube via a tiny discreet instrument. Moreover, wearable injectors also have wireless connectivity and their operations or functionalities can be regulated through software.
Rise in the occurrence of chronic ailments to drive the market expansion
The tremendous rise in the occurrence of chronic ailments like heart diseases, diabetes, and cancer will offer lucrative growth avenues for the market over the forecast timeline. According to the report of International Diabetes Federation, about 425 million persons were found be have been suffering from diabetes in 2017 and the figures are slated to hit nearly 629 million by 2045. Moreover, diabetic conditions need drug inoculation on time for maintaining normal body functioning. This will elevate the growth of the wearable injectors industry over the forecast timeline.
Furthermore, the launching of new technologies for maintaining the balance between disease management and lifestyles will further elevate the business growth during the forecast timeline. Moreover, technology has minimized the device size and made it user-friendly, thereby further accelerating the growth rate of the market over the forecast timeline. Nonetheless, growing acceptance of alternate modes of drug delivery will inhibit the scope of the market during the forecast timeframe.
On-body injectors to dominate the type segment by 2027
The users easily wear these devices and are handled by wireless connection & software. Moreover, technological breakthroughs have reduced the equipment size, thereby further steering the segmental growth over the forecast timeline.
Immuno-oncology segment to contribute majorly towards the overall market share by 2027
The growth of the segment during the forecast period is due to the high occurrence of cancer across the globe.
North America to lead the regional market growth during the period from 2019 to 2027
The growth of the market in North America is due to the presence of strong healthcare infrastructure along with growing incidences of chronic ailments. In addition to this, an increase in the research activities for biologics and the development of new injector design are a few of the major factors that are likely to steer the growth of the industry during the period from 2019 to 2027.
Furthermore, a rise in the acceptance of wearable injectors, favorable compensation policies, and bulge in healthcare spending are some of the aspects that will steer the regional market surge over the forecast timeline.
Top Market Players
The key market players for the global wearable injectors market are Becton, Dickinson and Company, Johnson & Johnson Services, Inc., F. Hoffman-La Roche Ltd., Unilife Corporation, SteadyMed Therapeutics, Inc., Amgen, Inc., Insulet Corporation, Enable Injections, West Pharmaceuticals Services, Inc., CeQur S.A., ATS Automation, Tandem Diabetes Care, and Noble, among others.
This report segments the Wearable Injectors market as follows:
Global Wearable Injectors Market: By Type Segment Analysis
- On-Body
- Off-Body
Global Wearable Injectors Market: ByTechnology Segment Analysis
- Spring-Based
- Motor-Driven
- Rotary Pump
- Expanding Battery
- Others
Global Wearable Injectors Market: By Application Segment Analysis
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Others
Global Wearable Injectors Market: By End-User Segment Analysis
- Hospitals
- Clinic
- Home Care Settings
- Others
Global Wearable Injectors Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Amgen Inc.
- ATS Automation
- Becton
- CeQur S.A.
- Dickinson and Company
- Enable Injections
Chapter 1 Executive Summary
1.1. Introduction of Wearable Injectors
1.2. Global Wearable Injectors Market, 2019 & 2026 (USD Billion)
1.3. Global Wearable Injectors Market, 2016 – 2026 (USD Billion)
1.4. Global Wearable Injectors Market Absolute Revenue Opportunity, 2016 – 2026 (USD Billion)
1.5. Global Wearable Injectors Market Incremental Revenue Opportunity, 2020 – 2026 (USD Billion)
Chapter 2 Wearable Injectors Market – Type Analysis
2.1. Global Wearable Injectors Market – Type Overview
2.2. Global Wearable Injectors Market Share, by Type, 2019 & 2026 (USD Billion)
2.3. On-Body
2.3.1. Global On-Body Wearable Injectors Market, 2016 – 2026 (USD Billion)
2.4. Off-Body
2.4.1. Global Off-Body Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 3 Wearable Injectors Market – Technology Analysis
3.1. Global Wearable Injectors Market – Technology Overview
3.2. Global Wearable Injectors Market Share, by Technology, 2019 & 2026 (USD Billion)
3.3. Spring-Based
3.3.1. Global Spring-Based Wearable Injectors Market, 2016 – 2026 (USD Billion)
3.4. Motor-Driven
3.4.1. Global Motor-Driven Wearable Injectors Market, 2016 – 2026 (USD Billion)
3.5. Rotary Pump
3.5.1. Global Rotary Pump Wearable Injectors Market, 2016 – 2026 (USD Billion)
3.6. Expanding Battery
3.6.1. Global Expanding Battery Wearable Injectors Market, 2016 – 2026 (USD Billion)
3.7. Others
3.7.1. Global Others Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 4 Wearable Injectors Market – Application Analysis
4.1. Global Wearable Injectors Market – Application Overview
4.2. Global Wearable Injectors Market Share, by Application, 2019 & 2026 (USD Billion)
4.3. Oncology
4.3.1. Global Oncology Wearable Injectors Market, 2016 – 2026 (USD Billion)
4.4. Infectious Diseases
4.4.1. Global Infectious Diseases Wearable Injectors Market, 2016 – 2026 (USD Billion)
4.5. Cardiovascular Diseases
4.5.1. Global Cardiovascular Diseases Wearable Injectors Market, 2016 – 2026 (USD Billion)
4.6. Autoimmune Diseases
4.6.1. Global Autoimmune Diseases Wearable Injectors Market, 2016 – 2026 (USD Billion)
4.7. Others
4.7.1. Global Others Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 5 Wearable Injectors Market – End-User Analysis
5.1. Global Wearable Injectors Market – End-User Overview
5.2. Global Wearable Injectors Market Share, by End-User, 2019 & 2026 (USD Billion)
5.3. Hospitals
5.3.1. Global Hospitals Wearable Injectors Market, 2016 – 2026 (USD Billion)
5.4. Clinic
5.4.1. Global Clinic Wearable Injectors Market, 2016 – 2026 (USD Billion)
5.5. Home Care Settings
5.5.1. Global Home Care Settings Wearable Injectors Market, 2016 – 2026 (USD Billion)
5.6. Others
5.6.1. Global Others Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 6 Wearable Injectors Market – Regional Analysis
6.1. Global Wearable Injectors Market Regional Overview
6.2. Global Wearable Injectors Market Share, by Region, 2019 & 2026 (USD Billion)
6.3. North America
6.3.1. North America Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.3.1.1. North America Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.3.2. North America Wearable Injectors Market, by Type, 2016 – 2026
6.3.2.1. North America Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.3.3. North America Wearable Injectors Market, by Technology, 2016 – 2026
6.3.3.1. North America Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.3.4. North America Wearable Injectors Market, by Application, 2016 – 2026
6.3.4.1. North America Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.3.5. North America Wearable Injectors Market, by End-User, 2016 – 2026
6.3.5.1. North America Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.3.6. U.S.
6.3.6.1. U.S. Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.3.7. Canada
6.3.7.1. Canada Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4. Europe
6.4.1. Europe Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.1.1. Europe Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.4.2. Europe Wearable Injectors Market, by Type, 2016 – 2026
6.4.2.1. Europe Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.4.3. Europe Wearable Injectors Market, by Technology, 2016 – 2026
6.4.3.1. Europe Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.4.4. Europe Wearable Injectors Market, by Application, 2016 – 2026
6.4.4.1. Europe Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.4.5. Europe Wearable Injectors Market, by End-User, 2016 – 2026
6.4.5.1. Europe Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.4.6. Germany
6.4.6.1. Germany Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.7. France
6.4.7.1. France Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.8. U.K.
6.4.8.1. U.K. Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.9. Italy
6.4.9.1. Italy Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.10. Spain
6.4.10.1. Spain Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.11. Rest of Europe
6.4.11.1. Rest of Europe Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5. Asia Pacific
6.5.1. Asia Pacific Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.1.1. Asia Pacific Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.5.2. Asia Pacific Wearable Injectors Market, by Type, 2016 – 2026
6.5.2.1. Asia Pacific Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.5.3. Asia Pacific Wearable Injectors Market, by Technology, 2016 – 2026
6.5.3.1. Asia Pacific Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.5.4. Asia Pacific Wearable Injectors Market, by Application, 2016 – 2026
6.5.4.1. Asia Pacific Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.5.5. Asia Pacific Wearable Injectors Market, by End-User, 2016 – 2026
6.5.5.1. Asia Pacific Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.5.6. China
6.5.6.1. China Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.7. Japan
6.5.7.1. Japan Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.8. India
6.5.8.1. India Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.9. South Korea
6.5.9.1. South Korea Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.10. South-East Asia
6.5.10.1. South-East Asia Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.11. Rest of Asia Pacific
6.5.11.1. Rest of Asia Pacific Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.6. Latin America
6.6.1. Latin America Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.6.1.1. Latin America Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.6.2. Latin America Wearable Injectors Market, by Type, 2016 – 2026
6.6.2.1. Latin America Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.6.3. Latin America Wearable Injectors Market, by Technology, 2016 – 2026
6.6.3.1. Latin America Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.6.4. Latin America Wearable Injectors Market, by Application, 2016 – 2026
6.6.4.1. Latin America Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.6.5. Latin America Wearable Injectors Market, by End-User, 2016 – 2026
6.6.5.1. Latin America Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.6.6. Brazil
6.6.6.1. Brazil Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.6.7. Mexico
6.6.7.1. Mexico Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.6.8. Rest of Latin America
6.6.8.1. Rest of Latin America Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.7. The Middle-East and Africa
6.7.1. The Middle-East and Africa Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.7.1.1. The Middle-East and Africa Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.7.2. The Middle-East and Africa Wearable Injectors Market, by Type, 2016 – 2026
6.7.2.1. The Middle-East and Africa Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.7.3. The Middle-East and Africa Wearable Injectors Market, by Technology, 2016 – 2026
6.7.3.1. The Middle-East and Africa Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.7.4. The Middle-East and Africa Wearable Injectors Market, by Application, 2016 – 2026
6.7.4.1. The Middle-East and Africa Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.7.5. The Middle-East and Africa Wearable Injectors Market, by End-User, 2016 – 2026
6.7.5.1. The Middle-East and Africa Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.7.6. GCC Countries
6.7.6.1. GCC Countries Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.7.7. South Africa
6.7.7.1. South Africa Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.7.8. Rest of Middle-East Africa
6.7.8.1. Rest of Middle-East Africa Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 7 Wearable Injectors Market – Competitive Landscape
7.1. Competitor Market Share – Revenue
7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
7.3. Strategic Developments
7.3.1. Acquisitions and Mergers
7.3.2. New Products
7.3.3. Research & Development Activities
Chapter 8 Company Profiles
8.1. Becton
8.1.1. Company Overview
8.1.2. Product/Service Portfolio
8.1.3. Becton Sales, Revenue, and Gross Margin
8.1.4. Becton Revenue and Growth Rate
8.1.5. Becton Market Share
8.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.2. Dickinson and Company
8.2.1. Company Overview
8.2.2. Product/Service Portfolio
8.2.3. Dickinson and Company Sales, Revenue, and Gross Margin
8.2.4. Dickinson and Company Revenue and Growth Rate
8.2.5. Dickinson and Company Market Share
8.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.3. Johnson & Johnson Services Inc
8.3.1. Company Overview
8.3.2. Product/Service Portfolio
8.3.3. Johnson & Johnson Services Inc Sales, Revenue, and Gross Margin
8.3.4. Johnson & Johnson Services Inc Revenue and Growth Rate
8.3.5. Johnson & Johnson Services Inc Market Share
8.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.4. F. Hoffman-La Roche Ltd
8.4.1. Company Overview
8.4.2. Product/Service Portfolio
8.4.3. F. Hoffman-La Roche Ltd Sales, Revenue, and Gross Margin
8.4.4. F. Hoffman-La Roche Ltd Revenue and Growth Rate
8.4.5. F. Hoffman-La Roche Ltd Market Share
8.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.5. Unilife Corporation
8.5.1. Company Overview
8.5.2. Product/Service Portfolio
8.5.3. Unilife Corporation Sales, Revenue, and Gross Margin
8.5.4. Unilife Corporation Revenue and Growth Rate
8.5.5. Unilife Corporation Market Share
8.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.6. SteadyMed Therapeutics Inc
8.6.1. Company Overview
8.6.2. Product/Service Portfolio
8.6.3. SteadyMed Therapeutics Inc Sales, Revenue, and Gross Margin
8.6.4. SteadyMed Therapeutics Inc Revenue and Growth Rate
8.6.5. SteadyMed Therapeutics Inc Market Share
8.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.7. Amgen Inc
8.7.1. Company Overview
8.7.2. Product/Service Portfolio
8.7.3. Amgen Inc Sales, Revenue, and Gross Margin
8.7.4. Amgen Inc Revenue and Growth Rate
8.7.5. Amgen Inc Market Share
8.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.8. Insulet Corporation
8.8.1. Company Overview
8.8.2. Product/Service Portfolio
8.8.3. Insulet Corporation Sales, Revenue, and Gross Margin
8.8.4. Insulet Corporation Revenue and Growth Rate
8.8.5. Insulet Corporation Market Share
8.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.9. Enable Injections
8.9.1. Company Overview
8.9.2. Product/Service Portfolio
8.9.3. Enable Injections Sales, Revenue, and Gross Margin
8.9.4. Enable Injections Revenue and Growth Rate
8.9.5. Enable Injections Market Share
8.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.10. West Pharmaceuticals Services Inc
8.10.1. Company Overview
8.10.2. Product/Service Portfolio
8.10.3. West Pharmaceuticals Services Inc Sales, Revenue, and Gross Margin
8.10.4. West Pharmaceuticals Services Inc Revenue and Growth Rate
8.10.5. West Pharmaceuticals Services Inc Market Share
8.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.11. CeQur S.A
8.11.1. Company Overview
8.11.2. Product/Service Portfolio
8.11.3. CeQur S.A Sales, Revenue, and Gross Margin
8.11.4. CeQur S.A Revenue and Growth Rate
8.11.5. CeQur S.A Market Share
8.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.12. ATS Automation
8.12.1. Company Overview
8.12.2. Product/Service Portfolio
8.12.3. ATS Automation Sales, Revenue, and Gross Margin
8.12.4. ATS Automation Revenue and Growth Rate
8.12.5. ATS Automation Market Share
8.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.13. Tandem Diabetes Care
8.13.1. Company Overview
8.13.2. Product/Service Portfolio
8.13.3. Tandem Diabetes Care Sales, Revenue, and Gross Margin
8.13.4. Tandem Diabetes Care Revenue and Growth Rate
8.13.5. Tandem Diabetes Care Market Share
8.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.14. Noble
8.14.1. Company Overview
8.14.2. Product/Service Portfolio
8.14.3. Noble Sales, Revenue, and Gross Margin
8.14.4. Noble Revenue and Growth Rate
8.14.5. Noble Market Share
8.14.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
Chapter 9 Wearable Injectors - Industry Analysis
9.1. Introduction and Taxonomy
9.2. Wearable Injectors Market – Key Trends
9.2.1. Market Drivers
9.2.2. Market Restraints
9.2.3. Market Opportunities
9.3. Value Chain Analysis
9.4. Key Mandates and Regulations
9.5. Technology Roadmap and Timeline
9.6. Wearable Injectors Market – Attractiveness Analysis
9.6.1. By Type
9.6.2. By Technology
9.6.3. By Application
9.6.4. By End-User
9.6.5. By Region
Chapter 10 Industrial Chain, Sourcing Strategy, and Downstream Buyers
10.1. Wearable Injectors Industrial Chain Analysis
10.2. Downstream Buyers
10.3. Distributors/Traders List
Chapter 11 Marketing Strategy Analysis
11.1. Marketing Channel
11.2. Direct Marketing
11.3. Indirect Marketing
11.4. Marketing Channel Development Trends
11.5. Economic/Political Environmental Change
Chapter 12 Report Conclusion & Key Insights
12.1. Key Insights from Primary Interviews & Surveys Respondents
12.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
Chapter 13 Research Approach & Methodology
13.1. Report Description
13.2. Research Scope
13.3. Research Methodology
13.3.1. Secondary Research
13.3.2. Primary Research
13.3.3. Statistical Models
13.3.3.1. Company Share Analysis Model
13.3.3.2. Revenue Based Modeling
13.3.4. Research Limitations
1.1. Introduction of Wearable Injectors
1.2. Global Wearable Injectors Market, 2019 & 2026 (USD Billion)
1.3. Global Wearable Injectors Market, 2016 – 2026 (USD Billion)
1.4. Global Wearable Injectors Market Absolute Revenue Opportunity, 2016 – 2026 (USD Billion)
1.5. Global Wearable Injectors Market Incremental Revenue Opportunity, 2020 – 2026 (USD Billion)
Chapter 2 Wearable Injectors Market – Type Analysis
2.1. Global Wearable Injectors Market – Type Overview
2.2. Global Wearable Injectors Market Share, by Type, 2019 & 2026 (USD Billion)
2.3. On-Body
2.3.1. Global On-Body Wearable Injectors Market, 2016 – 2026 (USD Billion)
2.4. Off-Body
2.4.1. Global Off-Body Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 3 Wearable Injectors Market – Technology Analysis
3.1. Global Wearable Injectors Market – Technology Overview
3.2. Global Wearable Injectors Market Share, by Technology, 2019 & 2026 (USD Billion)
3.3. Spring-Based
3.3.1. Global Spring-Based Wearable Injectors Market, 2016 – 2026 (USD Billion)
3.4. Motor-Driven
3.4.1. Global Motor-Driven Wearable Injectors Market, 2016 – 2026 (USD Billion)
3.5. Rotary Pump
3.5.1. Global Rotary Pump Wearable Injectors Market, 2016 – 2026 (USD Billion)
3.6. Expanding Battery
3.6.1. Global Expanding Battery Wearable Injectors Market, 2016 – 2026 (USD Billion)
3.7. Others
3.7.1. Global Others Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 4 Wearable Injectors Market – Application Analysis
4.1. Global Wearable Injectors Market – Application Overview
4.2. Global Wearable Injectors Market Share, by Application, 2019 & 2026 (USD Billion)
4.3. Oncology
4.3.1. Global Oncology Wearable Injectors Market, 2016 – 2026 (USD Billion)
4.4. Infectious Diseases
4.4.1. Global Infectious Diseases Wearable Injectors Market, 2016 – 2026 (USD Billion)
4.5. Cardiovascular Diseases
4.5.1. Global Cardiovascular Diseases Wearable Injectors Market, 2016 – 2026 (USD Billion)
4.6. Autoimmune Diseases
4.6.1. Global Autoimmune Diseases Wearable Injectors Market, 2016 – 2026 (USD Billion)
4.7. Others
4.7.1. Global Others Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 5 Wearable Injectors Market – End-User Analysis
5.1. Global Wearable Injectors Market – End-User Overview
5.2. Global Wearable Injectors Market Share, by End-User, 2019 & 2026 (USD Billion)
5.3. Hospitals
5.3.1. Global Hospitals Wearable Injectors Market, 2016 – 2026 (USD Billion)
5.4. Clinic
5.4.1. Global Clinic Wearable Injectors Market, 2016 – 2026 (USD Billion)
5.5. Home Care Settings
5.5.1. Global Home Care Settings Wearable Injectors Market, 2016 – 2026 (USD Billion)
5.6. Others
5.6.1. Global Others Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 6 Wearable Injectors Market – Regional Analysis
6.1. Global Wearable Injectors Market Regional Overview
6.2. Global Wearable Injectors Market Share, by Region, 2019 & 2026 (USD Billion)
6.3. North America
6.3.1. North America Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.3.1.1. North America Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.3.2. North America Wearable Injectors Market, by Type, 2016 – 2026
6.3.2.1. North America Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.3.3. North America Wearable Injectors Market, by Technology, 2016 – 2026
6.3.3.1. North America Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.3.4. North America Wearable Injectors Market, by Application, 2016 – 2026
6.3.4.1. North America Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.3.5. North America Wearable Injectors Market, by End-User, 2016 – 2026
6.3.5.1. North America Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.3.6. U.S.
6.3.6.1. U.S. Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.3.7. Canada
6.3.7.1. Canada Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4. Europe
6.4.1. Europe Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.1.1. Europe Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.4.2. Europe Wearable Injectors Market, by Type, 2016 – 2026
6.4.2.1. Europe Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.4.3. Europe Wearable Injectors Market, by Technology, 2016 – 2026
6.4.3.1. Europe Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.4.4. Europe Wearable Injectors Market, by Application, 2016 – 2026
6.4.4.1. Europe Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.4.5. Europe Wearable Injectors Market, by End-User, 2016 – 2026
6.4.5.1. Europe Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.4.6. Germany
6.4.6.1. Germany Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.7. France
6.4.7.1. France Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.8. U.K.
6.4.8.1. U.K. Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.9. Italy
6.4.9.1. Italy Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.10. Spain
6.4.10.1. Spain Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.4.11. Rest of Europe
6.4.11.1. Rest of Europe Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5. Asia Pacific
6.5.1. Asia Pacific Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.1.1. Asia Pacific Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.5.2. Asia Pacific Wearable Injectors Market, by Type, 2016 – 2026
6.5.2.1. Asia Pacific Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.5.3. Asia Pacific Wearable Injectors Market, by Technology, 2016 – 2026
6.5.3.1. Asia Pacific Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.5.4. Asia Pacific Wearable Injectors Market, by Application, 2016 – 2026
6.5.4.1. Asia Pacific Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.5.5. Asia Pacific Wearable Injectors Market, by End-User, 2016 – 2026
6.5.5.1. Asia Pacific Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.5.6. China
6.5.6.1. China Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.7. Japan
6.5.7.1. Japan Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.8. India
6.5.8.1. India Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.9. South Korea
6.5.9.1. South Korea Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.10. South-East Asia
6.5.10.1. South-East Asia Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.5.11. Rest of Asia Pacific
6.5.11.1. Rest of Asia Pacific Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.6. Latin America
6.6.1. Latin America Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.6.1.1. Latin America Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.6.2. Latin America Wearable Injectors Market, by Type, 2016 – 2026
6.6.2.1. Latin America Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.6.3. Latin America Wearable Injectors Market, by Technology, 2016 – 2026
6.6.3.1. Latin America Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.6.4. Latin America Wearable Injectors Market, by Application, 2016 – 2026
6.6.4.1. Latin America Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.6.5. Latin America Wearable Injectors Market, by End-User, 2016 – 2026
6.6.5.1. Latin America Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.6.6. Brazil
6.6.6.1. Brazil Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.6.7. Mexico
6.6.7.1. Mexico Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.6.8. Rest of Latin America
6.6.8.1. Rest of Latin America Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.7. The Middle-East and Africa
6.7.1. The Middle-East and Africa Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.7.1.1. The Middle-East and Africa Wearable Injectors Market, by Country, 2016 - 2026 (USD Billion)
6.7.2. The Middle-East and Africa Wearable Injectors Market, by Type, 2016 – 2026
6.7.2.1. The Middle-East and Africa Wearable Injectors Market, by Type, 2016 – 2026 (USD Billion)
6.7.3. The Middle-East and Africa Wearable Injectors Market, by Technology, 2016 – 2026
6.7.3.1. The Middle-East and Africa Wearable Injectors Market, by Technology, 2016 – 2026 (USD Billion)
6.7.4. The Middle-East and Africa Wearable Injectors Market, by Application, 2016 – 2026
6.7.4.1. The Middle-East and Africa Wearable Injectors Market, by Application, 2016 – 2026 (USD Billion)
6.7.5. The Middle-East and Africa Wearable Injectors Market, by End-User, 2016 – 2026
6.7.5.1. The Middle-East and Africa Wearable Injectors Market, by End-User, 2016 – 2026 (USD Billion)
6.7.6. GCC Countries
6.7.6.1. GCC Countries Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.7.7. South Africa
6.7.7.1. South Africa Wearable Injectors Market, 2016 – 2026 (USD Billion)
6.7.8. Rest of Middle-East Africa
6.7.8.1. Rest of Middle-East Africa Wearable Injectors Market, 2016 – 2026 (USD Billion)
Chapter 7 Wearable Injectors Market – Competitive Landscape
7.1. Competitor Market Share – Revenue
7.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
7.3. Strategic Developments
7.3.1. Acquisitions and Mergers
7.3.2. New Products
7.3.3. Research & Development Activities
Chapter 8 Company Profiles
8.1. Becton
8.1.1. Company Overview
8.1.2. Product/Service Portfolio
8.1.3. Becton Sales, Revenue, and Gross Margin
8.1.4. Becton Revenue and Growth Rate
8.1.5. Becton Market Share
8.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.2. Dickinson and Company
8.2.1. Company Overview
8.2.2. Product/Service Portfolio
8.2.3. Dickinson and Company Sales, Revenue, and Gross Margin
8.2.4. Dickinson and Company Revenue and Growth Rate
8.2.5. Dickinson and Company Market Share
8.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.3. Johnson & Johnson Services Inc
8.3.1. Company Overview
8.3.2. Product/Service Portfolio
8.3.3. Johnson & Johnson Services Inc Sales, Revenue, and Gross Margin
8.3.4. Johnson & Johnson Services Inc Revenue and Growth Rate
8.3.5. Johnson & Johnson Services Inc Market Share
8.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.4. F. Hoffman-La Roche Ltd
8.4.1. Company Overview
8.4.2. Product/Service Portfolio
8.4.3. F. Hoffman-La Roche Ltd Sales, Revenue, and Gross Margin
8.4.4. F. Hoffman-La Roche Ltd Revenue and Growth Rate
8.4.5. F. Hoffman-La Roche Ltd Market Share
8.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.5. Unilife Corporation
8.5.1. Company Overview
8.5.2. Product/Service Portfolio
8.5.3. Unilife Corporation Sales, Revenue, and Gross Margin
8.5.4. Unilife Corporation Revenue and Growth Rate
8.5.5. Unilife Corporation Market Share
8.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.6. SteadyMed Therapeutics Inc
8.6.1. Company Overview
8.6.2. Product/Service Portfolio
8.6.3. SteadyMed Therapeutics Inc Sales, Revenue, and Gross Margin
8.6.4. SteadyMed Therapeutics Inc Revenue and Growth Rate
8.6.5. SteadyMed Therapeutics Inc Market Share
8.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.7. Amgen Inc
8.7.1. Company Overview
8.7.2. Product/Service Portfolio
8.7.3. Amgen Inc Sales, Revenue, and Gross Margin
8.7.4. Amgen Inc Revenue and Growth Rate
8.7.5. Amgen Inc Market Share
8.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.8. Insulet Corporation
8.8.1. Company Overview
8.8.2. Product/Service Portfolio
8.8.3. Insulet Corporation Sales, Revenue, and Gross Margin
8.8.4. Insulet Corporation Revenue and Growth Rate
8.8.5. Insulet Corporation Market Share
8.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.9. Enable Injections
8.9.1. Company Overview
8.9.2. Product/Service Portfolio
8.9.3. Enable Injections Sales, Revenue, and Gross Margin
8.9.4. Enable Injections Revenue and Growth Rate
8.9.5. Enable Injections Market Share
8.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.10. West Pharmaceuticals Services Inc
8.10.1. Company Overview
8.10.2. Product/Service Portfolio
8.10.3. West Pharmaceuticals Services Inc Sales, Revenue, and Gross Margin
8.10.4. West Pharmaceuticals Services Inc Revenue and Growth Rate
8.10.5. West Pharmaceuticals Services Inc Market Share
8.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.11. CeQur S.A
8.11.1. Company Overview
8.11.2. Product/Service Portfolio
8.11.3. CeQur S.A Sales, Revenue, and Gross Margin
8.11.4. CeQur S.A Revenue and Growth Rate
8.11.5. CeQur S.A Market Share
8.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.12. ATS Automation
8.12.1. Company Overview
8.12.2. Product/Service Portfolio
8.12.3. ATS Automation Sales, Revenue, and Gross Margin
8.12.4. ATS Automation Revenue and Growth Rate
8.12.5. ATS Automation Market Share
8.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.13. Tandem Diabetes Care
8.13.1. Company Overview
8.13.2. Product/Service Portfolio
8.13.3. Tandem Diabetes Care Sales, Revenue, and Gross Margin
8.13.4. Tandem Diabetes Care Revenue and Growth Rate
8.13.5. Tandem Diabetes Care Market Share
8.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
8.14. Noble
8.14.1. Company Overview
8.14.2. Product/Service Portfolio
8.14.3. Noble Sales, Revenue, and Gross Margin
8.14.4. Noble Revenue and Growth Rate
8.14.5. Noble Market Share
8.14.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
Chapter 9 Wearable Injectors - Industry Analysis
9.1. Introduction and Taxonomy
9.2. Wearable Injectors Market – Key Trends
9.2.1. Market Drivers
9.2.2. Market Restraints
9.2.3. Market Opportunities
9.3. Value Chain Analysis
9.4. Key Mandates and Regulations
9.5. Technology Roadmap and Timeline
9.6. Wearable Injectors Market – Attractiveness Analysis
9.6.1. By Type
9.6.2. By Technology
9.6.3. By Application
9.6.4. By End-User
9.6.5. By Region
Chapter 10 Industrial Chain, Sourcing Strategy, and Downstream Buyers
10.1. Wearable Injectors Industrial Chain Analysis
10.2. Downstream Buyers
10.3. Distributors/Traders List
Chapter 11 Marketing Strategy Analysis
11.1. Marketing Channel
11.2. Direct Marketing
11.3. Indirect Marketing
11.4. Marketing Channel Development Trends
11.5. Economic/Political Environmental Change
Chapter 12 Report Conclusion & Key Insights
12.1. Key Insights from Primary Interviews & Surveys Respondents
12.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
Chapter 13 Research Approach & Methodology
13.1. Report Description
13.2. Research Scope
13.3. Research Methodology
13.3.1. Secondary Research
13.3.2. Primary Research
13.3.3. Statistical Models
13.3.3.1. Company Share Analysis Model
13.3.3.2. Revenue Based Modeling
13.3.4. Research Limitations
Note: Product cover images may vary from those shown
- Becton
- Dickinson and Company
- Johnson & Johnson Services Inc.
- F. Hoffman-La Roche Ltd.
- Unilife Corporation
- SteadyMed Therapeutics Inc.
- Amgen Inc.
- Insulet Corporation
- Enable Injections
- West Pharmaceuticals Services Inc.
- CeQur S.A.
- ATS Automation
- Tandem Diabetes Care
- Noble
Note: Product cover images may vary from those shown
LOADING...
